Ingrid Galán

3.5k total citations · 1 hit paper
40 papers, 1.9k citations indexed

About

Ingrid Galán is a scholar working on Pathology and Forensic Medicine, Rheumatology and Neurology. According to data from OpenAlex, Ingrid Galán has authored 40 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pathology and Forensic Medicine, 14 papers in Rheumatology and 11 papers in Neurology. Recurrent topics in Ingrid Galán's work include Multiple Sclerosis Research Studies (29 papers), Peripheral Neuropathies and Disorders (7 papers) and Polyomavirus and related diseases (7 papers). Ingrid Galán is often cited by papers focused on Multiple Sclerosis Research Studies (29 papers), Peripheral Neuropathies and Disorders (7 papers) and Polyomavirus and related diseases (7 papers). Ingrid Galán collaborates with scholars based in Spain, United States and Italy. Ingrid Galán's co-authors include Xavier Montalbán, Jordi Río, Mar Tintoré, Carlos Nos, Manuel Comabella, Jaume Sastre‐Garriga, N. Téllez, Àlex Rovira, Ángela Vidal‐Jordana and Georgina Arrambide and has published in prestigious journals such as PLoS ONE, Brain and Neurology.

In The Last Decade

Ingrid Galán

39 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

2015 358 citations Mar Tintoré, Àlex Rovira et al. Brain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingrid Galán Spain	21	1.6k	643	475	346	231	40	1.9k
Ali Manouchehrinia Sweden	25	1.6k 1.0×	503 0.8×	355 0.7×	264 0.8×	178 0.8×	73	2.1k
Enrico Millefiorini Italy	24	1.4k 0.9×	698 1.1×	354 0.7×	346 1.0×	236 1.0×	62	1.9k
Antonio Scalfari United Kingdom	18	1.7k 1.1×	588 0.9×	478 1.0×	338 1.0×	116 0.5×	46	1.9k
Tomáš Kalinčík Australia	23	1.5k 1.0×	514 0.8×	361 0.8×	293 0.8×	144 0.6×	140	2.0k
Ilya Kister United States	33	2.0k 1.3×	981 1.5×	382 0.8×	346 1.0×	299 1.3×	110	2.7k
Marc Debouverie France	27	2.1k 1.4×	885 1.4×	559 1.2×	385 1.1×	244 1.1×	89	2.7k
Ludwig Kappos Switzerland	17	973 0.6×	479 0.7×	242 0.5×	346 1.0×	232 1.0×	59	1.6k
Norman Putzki Switzerland	25	1.6k 1.0×	668 1.0×	293 0.6×	390 1.1×	246 1.1×	48	2.1k
Wilma J. Koopman Canada	17	1.1k 0.7×	874 1.4×	379 0.8×	194 0.6×	140 0.6×	37	1.9k
Rainer Ehling Austria	21	1.1k 0.7×	792 1.2×	372 0.8×	191 0.6×	98 0.4×	52	1.8k

Countries citing papers authored by Ingrid Galán

Since Specialization

Citations

This map shows the geographic impact of Ingrid Galán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Galán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Galán more than expected).

Fields of papers citing papers by Ingrid Galán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Galán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Galán. The network helps show where Ingrid Galán may publish in the future.

Co-authorship network of co-authors of Ingrid Galán

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Galán. A scholar is included among the top collaborators of Ingrid Galán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Galán. Ingrid Galán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giovannetti, Ambra Mara, Rosalba Rosato, Ingrid Galán, et al.. (2024). Cross-cultural validity and reliability of the comprehensive assessment of acceptance and commitment therapy processes (CompACT) in people with multiple sclerosis. Quality of Life Research. 33(5). 1359–1371. 1 indexed citations

Pareto, Deborah, Koen Cuypers, Raf Meesen, et al.. (2022). Can Cognitive training Reignite Compensatory Mechanisms in Advanced Multiple Sclerosis Patients? An Explorative Morphological Network Approach. Neuroscience. 495. 86–96. 3 indexed citations

Otero‐Romero, Susana, Pere Carbonell‐Mirabent, Luciana Midaglia, et al.. (2021). Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis. Multiple Sclerosis Journal. 28(6). 950–957. 9 indexed citations

Midaglia, Luciana, Jaume Sastre‐Garriga, Agustín Pappolla, et al.. (2021). The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia. Multiple Sclerosis Journal. 27(6). 913–921. 21 indexed citations

Río, Jordi, Àlex Rovira, Claudio Gasperini, et al.. (2021). Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients. Journal of Neurology. 269(1). 452–459. 7 indexed citations

Arrambide, Georgina, Àlex Rovira, Jaume Sastre‐Garriga, et al.. (2017). Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Multiple Sclerosis Journal. 24(3). 301–312. 77 indexed citations

Galán, Ingrid, et al.. (2016). Patrimonio documental: su producción científica registrada en la Base de Datos Scopus en los últimos 30 años.. Revista Publicando. 3(6). 512–549. 3 indexed citations

Galán, Ingrid, et al.. (2015). Patrimonio documental, memoria e identidad: una mirada desde las Ciencias de la Información. Ciencias de la información. 46(2). 29–34. 2 indexed citations

Tintoré, Mar, Àlex Rovira, Jordi Río, et al.. (2015). Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain. 138(7). 1863–1874. 358 indexed citations breakdown →

10.

Tur, Carmen, Mar Tintoré, Ángela Vidal‐Jordana, et al.. (2013). Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment. PLoS ONE. 8(12). e82796–e82796. 24 indexed citations

11.

Lucas‐Carrasco, Ramona, Jaume Sastre‐Garriga, Ingrid Galán, Brenda L. Den Oudsten, & Mick Power. (2013). Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis. Disability and Rehabilitation. 36(12). 1001–1005. 23 indexed citations

12.

Lucas‐Carrasco, Ramona, Berta Pascual‐Sedano, Ingrid Galán, et al.. (2010). Using the WHOQOL-DIS to Measure Quality of Life in Persons with Physical Disabilities Caused by Neurodegenerative Disorders. Neurodegenerative Diseases. 8(4). 178–186. 26 indexed citations

13.

Río, Jordi, Alberto Luis Fernández, Mar Tintoré, et al.. (2009). Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acta Neurologica Scandinavica. 93(2-3). 99–103. 20 indexed citations

14.

Sastre‐Garriga, Jaume, María Jesús Arévalo, Juli Alonso, et al.. (2009). Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis. Journal of the Neurological Sciences. 282(1-2). 120–124. 26 indexed citations

15.

Río, Jordi, Mar Tintoré, Carlos Nos, et al.. (2007). Interferon beta in secondary progressive multiple sclerosis. Journal of Neurology. 254(7). 849–853. 23 indexed citations

16.

Río, Jordi, Carlos Nos, Mar Tintoré, et al.. (2006). Defining the response to interferon‐β in relapsing‐remitting multiple sclerosis patients. Annals of Neurology. 59(2). 344–352. 259 indexed citations

17.

Río, Jordi, Mar Tintoré, Nieves Téllez, et al.. (2005). Efecto a largo plazo de los anticuerpos neutralizantes de interferón beta-1 b en pacientes con esclerosis múltiple. Medicina Clínica. 124(4). 140–141. 1 indexed citations

18.

Río, Jordi, Mar Tintoré, Carlos Nos, et al.. (2005). Interferon beta in relapsing–remitting multiple sclerosis. Journal of Neurology. 252(7). 795–800. 46 indexed citations

19.

Río, Jordi, Carlos Nos, Mar Tintoré, et al.. (2002). Assessment of different treatment failure criteria in a cohort of relapsing–remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials. Annals of Neurology. 52(4). 400–406. 107 indexed citations

20.

Montalbán, Xavier, et al.. (1996). [Interobserver variability in the evaluation of functional systems and Kurzke expanded disability status scale in a multiple sclerosis patient].. PubMed. 24(130). 630–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact